Patents by Inventor Christopher J. Oalmann

Christopher J. Oalmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TLR2 MODULATOR COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
    Publication number: 20240156780
    Abstract: The present disclosure relates to compounds which modulate the activity of Toll-like receptor (TLR) proteins, including agonists or activators, partial agonists, and antagonists. Of particular interest of compounds that modulate the activity of TLR2, as well as methods of using such compounds to treat cancer and other disorders associated with a TLR2 pathway.
    Type: Application
    Filed: November 17, 2023
    Publication date: May 16, 2024
    Applicant: Axial Therapeutics, Inc.
    Inventors: Christopher J. Oalmann, Dennis S. Yamashita, Patrick J. Stern
  • TLR2 modulator compounds, pharmaceutical compositions and uses thereof
    Patent number: 11951094
    Abstract: The present disclosure relates to compounds which modulate the activity of Toll-like receptor (TLR) proteins, including agonists or activators, partial agonists, and antagonists. Of particular interest of compounds that modulate the activity of TLR2, as well as methods of using such compounds to treat cancer and other disorders associated with a TLR2 pathway.
    Type: Grant
    Filed: June 15, 2022
    Date of Patent: April 9, 2024
    Assignee: Axial Therapeutics, Inc.
    Inventors: Christopher J. Oalmann, Dennis S. Yamashita, Patrick J. Stern
  • INHIBITORS OF MICROBIALLY INDUCED AMYLOID
    Publication number: 20230131899
    Abstract: The present disclosure provides compounds useful for the prevention of amyloid formation and the treatment of amyloid related disorders, including synucleopathies such as Parkinson's Disease.
    Type: Application
    Filed: January 8, 2021
    Publication date: April 27, 2023
    Applicant: Axial Therapeutics, Inc.
    Inventors: Anthony Stewart Campbell, Christopher J. Oalmann, Dennis S. Yamashita
  • TLR2 MODULATOR COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
    Publication number: 20230051773
    Abstract: The present disclosure relates to compounds which modulate the activity of Toll-like receptor (TLR) proteins, including agonists or activators, partial agonists, and antagonists. Of particular interest of compounds that modulate the activity of TLR2, as well as methods of using such compounds to treat cancer and other disorders associated with a TLR2 pathway.
    Type: Application
    Filed: June 15, 2022
    Publication date: February 16, 2023
    Applicant: Axial Therapeutics, Inc.
    Inventors: Christopher J. Oalmann, Dennis S. Yamashita, Patrick J. Stern